光學基因組圖譜市場規模、佔有率和成長分析（按產品、技術、應用、組件和地區分類）—2026-2033年產業預測

全球光學基因組圖譜市場規模預計在 2024 年達到 1.4047 億美元，從 2025 年的 1.7025 億美元成長到 2033 年的 7.927 億美元，在預測期（2026-2033 年）內複合年成長率為 21.2%。

市場趨勢表明，隨著越來越多的實驗室尋求可靠地識別短讀定序無法識別的結構變異，對光學基因組圖譜（OGM）的需求正在成長。儀器和試劑租賃協議的廣泛普及，以及化學和流動池技術的進步提高了通量並降低了每個樣本的成本，使得OGM的應用範圍顯著擴大。供應商正透過自動化、基於雲端的分析和標準化報告來最佳化工作流程，從而提高腫瘤學、骨髓惡性腫瘤、罕見疾病以及細胞和基因治療品管的可重複性。 OGM的應用正從研究試點階段轉向廣泛應用，收入來源也轉向耗材、軟體和服務。關鍵趨勢包括與次世代定序的整合、人工智慧驅動的變異檢測以及集中式分析網路的構建，儘管在資本投資、數據解讀和臨床檢驗仍然存在挑戰。總而言之，OGM正在成為生物製藥和全球實驗室營運中增強基因組分析的關鍵高解析度平台。

全球光學基因組圖譜市場促進因素

隨著越來越多的實驗室採用無縫整合光學基因組圖譜和定序技術的端到端綜合流程，全球光學基因組圖譜市場正經歷顯著成長。這種整合利用標準化流程、參考樣本和先進的判讀規則來應對複雜的基因重排，確保不同實驗室獲得一致且可重複的結果。大規模隊列研究和不斷變化的報告要求推動了重複試劑盒的日益普及，同時，基於雲端的加速分析也提高了多站點環境下的周轉時間和人員效率。這些進步共同促進了基因研究和診斷領域的市場擴張和創新。

限制全球光學基因組圖譜市場發展的因素

全球光學基因組圖譜市場面臨許多挑戰，可能阻礙其擴張。對結構變異進行分診、分類和報告所需的專業知識增加了操作的複雜性，尤其對於小規模的隊列而言，分析和品管可能面臨許多困難。此外，全面的審核文件要求也增加了營運工作量。缺乏標準化的雲端解決方案和完善的標準作業規程 (SOP) 會導致不同站點之間出現不一致，從而限制吞吐量，阻礙研究原型向成熟服務產品的過渡，最終成為市場成長的障礙。

全球光學基因組圖譜市場趨勢

由於採用混合型光學基因組圖譜（OGM）-定序報告方法的進步，全球OGM市場正經歷顯著成長。這些創新方法透過整合光學圖譜和定序技術，實現了全面的基因組表徵，從而能夠精確檢測大規模基因組重排，並識別斷點和突變。這一趨勢提高了數據分析效率，縮短了審核週期，並促進了腫瘤學、血液學和遺傳學等領域的跨學科合作。隨著整合流程和標準化報告方法的普及，對OGM解決方案的需求預計將持續成長，進一步塑造基因組分析和個人化醫療的模式。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 案例研究

全球光學基因組圖譜市場規模（依產品/服務分類）及複合年成長率（2026-2033 年）

• 裝置
• 耗材和試劑
• 軟體和服務

全球光學基因組圖譜市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 結構突變檢測
• 基因組組裝
• 微生物菌株分型
• 罕見變異的識別

全球光學基因組圖譜市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 生物技術和製藥公司
• 醫院和臨床檢查室
• 學術機構
• 受託研究機構（CRO）

全球光學基因組圖譜市場規模（按組件分類）及複合年成長率（2026-2033 年）

• 硬體
• 軟體

全球光學基因組圖譜市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Bionano Genomics
• Pacific Biosciences
• Oxford Nanopore Technologies
• Illumina
• Thermo Fisher Scientific
• Agilent Technologies
• Qiagen
• Roche
• Bio-Rad Laboratories
• Revvity（PerkinElmer）
• Cytiva（Danaher）
• 10x Genomics

結論與建議

Global Optical Genome Mapping Market size was valued at USD 140.47 Million in 2024 and is poised to grow from USD 170.25 Million in 2025 to USD 792.7 Million by 2033, growing at a CAGR of 21.2% during the forecast period (2026-2033).

Market insights indicate a growing demand for Optical Genome Mapping (OGM) due to laboratories seeking reliable identification of structural variants that surpass the capabilities of short-read sequencing. Expanded access is evident as instrument placements and reagent-rental agreements become more prevalent, complemented by advancements in chemistry and flow cell technology that enhance throughput while reducing cost per sample. Vendors are optimizing workflows through automation, cloud-based analysis, and standardized reporting, fostering reproducibility across oncology, hematologic malignancies, rare diseases, and cell and gene therapy quality control. Adoption is transitioning from research pilots to widespread application, shifting revenue towards consumables, software, and services. Key trends include the integration of OGM with next-generation sequencing, AI-driven variant calling, and the establishment of centralized analysis networks, despite ongoing challenges in capital investment, data interpretation, and clinical validation. Overall, OGM is emerging as a vital, high-resolution platform enhancing genome analysis for biopharmaceutical and laboratory operations globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Optical Genome Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Optical Genome Mapping Market Segments Analysis

Global Optical Genome Mapping Market is segmented by Product, Technique, End-Use, Component and region. Based on Product, the market is segmented into Instruments, Consumables & Reagents and Software and Services. Based on Technique, the market is segmented into Structural Variant Detection, Genome Assembly, Microbial Strain Typing and Rare Variant Identification. Based on End-Use, the market is segmented into Biotech & Pharma Companies, Hospitals & Clinical Labs, Academic Institutes and Contract Research Organizations (CROs). Based on Component, the market is segmented into Hardware and Software. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Optical Genome Mapping Market

The Global Optical Genome Mapping market is experiencing significant growth due to laboratories adopting comprehensive end-to-end processes that seamlessly combine optical genome mapping with sequencing techniques. This integration addresses complex genetic rearrangements by utilizing standardized pipelines, reference samples, and sophisticated interpretation rules, ensuring consistent and reproducible results across different sites. The increasing utilization of repeat kits, driven by larger cohort sizes and evolving reporting obligations, along with the acceleration of cloud-based analysis, enhances turnaround times and staff efficiency in multi-site settings. These advancements collectively contribute to the market's expansion and innovation in genetic research and diagnostics.

Restraints in the Global Optical Genome Mapping Market

The global optical genome mapping market faces several challenges that can hinder its expansion. The necessity for specialist expertise in the triage, classification, and reporting of structural variants complicates operations, particularly for smaller cohorts that may struggle with analysis and quality control due to steep learning curves. Additionally, the requirement for comprehensive audit documentation adds to the operational workload. Without standardized cloud solutions and well-defined standard operating procedures, inconsistencies across different sites may arise, limiting throughput and impeding the transition from research prototypes to established service offerings, ultimately acting as a barrier to market growth.

Market Trends of the Global Optical Genome Mapping Market

The global Optical Genome Mapping (OGM) market is experiencing significant growth driven by advancements in hybrid OGM-sequencing reporting methods. These innovative approaches facilitate comprehensive genome characterization through the integration of optical mapping and sequencing technologies, allowing for the precise detection of large genomic rearrangements alongside breakpoint and variant identification. This trend enhances data analysis efficiency, reduces review cycles, and promotes interdisciplinary collaboration in fields such as oncology, hematology, and constitutional genetics. As integrated pipelines and harmonized reporting methods become standard, the demand for OGM solutions is poised to rise, further shaping the landscape of genomic analysis and personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Optical Genome Mapping Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Instruments
• Consumables & Reagents
• Software and Services

Global Optical Genome Mapping Market Size by Technique & CAGR (2026-2033)

• Market Overview
• Structural Variant Detection
• Genome Assembly
• Microbial Strain Typing
• Rare Variant Identification

Global Optical Genome Mapping Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Biotech & Pharma Companies
• Hospitals & Clinical Labs
• Academic Institutes
• Contract Research Organizations (CROs)

Global Optical Genome Mapping Market Size by Component & CAGR (2026-2033)

• Market Overview
• Hardware
• Software

Global Optical Genome Mapping Market Size & CAGR (2026-2033)

• North America (Product & Service, Technique, End-Use, Component)
  • US
  • Canada
• Europe (Product & Service, Technique, End-Use, Component)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Technique, End-Use, Component)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Technique, End-Use, Component)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Technique, End-Use, Component)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bionano Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (PerkinElmer)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (Danaher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations